Sign In
Buy GMED
$77.95
-0.300 (-0.383%)
At Close: Jun 03, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Globus Medical, Inc. – GMED
01:37pm, Tuesday, 13'th May 2025
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED). Such investors are a
GMED Q1 Earnings & Revenues Miss, '25 EPS View Down, Stock Falls
08:26am, Monday, 12'th May 2025
GMED's first-quarter 2025 weak performance reflects soft Enabling Technology deal closures.
Globus Medical, Inc. (GMED) Q1 2025 Earnings Call Transcript
10:32pm, Thursday, 08'th May 2025
Globus Medical, Inc. (NYSE:GMED ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development & IR Dan Scavilla - President & CEO Keith Pfeil
Globus Medical (GMED) Reports Q1 Earnings: What Key Metrics Have to Say
07:30pm, Thursday, 08'th May 2025
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street e
Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates
06:50pm, Thursday, 08'th May 2025
Globus Medical (GMED) came out with quarterly earnings of $0.68 per share, missing the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.72 per share a year ago.
Globus Medical Reports First Quarter 2025 Results
04:15pm, Thursday, 08'th May 2025
AUDUBON, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 20
Gear Up for Globus Medical (GMED) Q1 Earnings: Wall Street Estimates for Key Metrics
10:20am, Monday, 05'th May 2025
Beyond analysts' top -and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the
Globus Medical (GMED) Earnings Expected to Grow: Should You Buy?
11:07am, Thursday, 01'st May 2025
Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates
08:30am, Thursday, 01'st May 2025
MedTech companies' quarterly results are likely to reflect base business recovery on a year-over-year basis. Let's see how HIMS, GMED, QDRL and HAE are poised ahead of their earnings release.
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term
10:45am, Tuesday, 22'nd Apr 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock?
10:15am, Tuesday, 22'nd Apr 2025
Investors need to pay close attention to Globus Medical (GMED) stock based on the movements in the options market lately.
Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?
01:15pm, Friday, 18'th Apr 2025
Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Globus Medical Schedules First Quarter Earnings Release and Conference Call
04:30pm, Thursday, 17'th Apr 2025
AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 3
International Growth Drives GMED Stock Amid Fierce Competition
01:20pm, Monday, 14'th Apr 2025
Globus Medical is gearing up for a series of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.
GMED Stock May Benefit Following the Acquisition of Nevro
09:40am, Monday, 07'th Apr 2025
Globus Medical acquires Nevro Corp. to expand its presence in the $2.50 billion musculoskeletal market.
